Publications by authors named "Steven D Gore"

Claim this Profile
H
High-throughput combination screening of Pidnarulex and other G-quadruplex ligands in multi-cell type tumor spheroids.
Thomas S Dexheimer, Nathan P Coussens, Thomas Silvers, Poorva Juneja, Eric Jones, Steven D Gore

SLAS Discov· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The ATR Inhibitor Elimusertib in Combination with Cisplatin in Patients with Advanced Solid Tumors: A California Cancer Consortium Phase I Trial (NCI 10404).
Mamta Parikh, Nataliya V Uboha, Naoko Takebe, Kit Tam, Philippe L Bedard, Steven D Gore

Cancer Res Commun· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 clinical trial of the ataxia telangiectasia and Rad3-related inhibitor berzosertib with irinotecan in patients with advanced solid tumors (ETCTN 9938).
Liza C Villaruz, Jingxiao Jin, Hong Wang, James J Lee, Jason J Luke, Steven D Gore

Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RNA processing kinase inhibitors and epigenetic inhibitors in combination with oncology drugs or investigational agents in multi-cell type patient-derived tumor cell line spheroids.
Beverly A Teicher, Thomas S Dexheimer, Thomas Silvers, Nathan P Coussens, Eric Jones, Steven D Gore

Cancer Chemother Pharmacol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitation of Tuvusertib (M1774) in Human Plasma by LC-MS/MS.
Tien V Le, Robert A Parise, Julianne L Holleran, Christopher J Bakkenist, Timothy Synold, Steven D Gore

Biomed Chromatogr· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RNA processing kinase inhibitors and epigenetic inhibitors in combination with oncology drugs or investigational agents in multi-cell type patient-derived tumor cell line spheroids.
Beverly A Teicher, Thomas S Dexheimer, Thomas Silvers, Nathan P Coussens, Eric Jones, Steven D Gore

Res Sq· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elderberry wine and promyelocytic leukemia.
Steven D Gore

Blood Adv· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1 study of the combination of BH3-mimetic, navitoclax, and mTORC1/2 inhibitor, vistusertib, in patients with advanced solid tumors.
Susan C Scott, Anna Farago, W Victoria Lai, Marianna Zahurak, Michelle A Rudek, Steven D Gore

Cancer Chemother Pharmacol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contemporary Approach to the Diagnosis and Classification of Myelodysplastic Neoplasms/Syndromes-Recommendations From the International Consortium for Myelodysplastic Neoplasms/Syndromes (MDS [icMDS]).
Fnu Aakash, Savanah D Gisriel, Amer M Zeidan, John M Bennett, Rafael Bejar, Steven D Gore

Mod Pathol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Data-driven, harmonised classification system for myelodysplastic syndromes: a consensus paper from the International Consortium for Myelodysplastic Syndromes.
Rami S Komrokji, Luca Lanino, Somedeb Ball, Jan P Bewersdorf, Monia Marchetti, Steven D Gore

Lancet Haematol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation between peripheral blood and bone marrow mutations among patients with MDS from the National MDS Study.
Amy E DeZern, Johannes B Goll, Travis L Jensen, Sridhar Nonavinkere Srivatsan, Nancy K Gillis, Steven D Gore

Blood Neoplasia· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults.
Mark R Litzow, Zhuoxin Sun, Ryan J Mattison, Elisabeth M Paietta, Kathryn G Roberts, Steven D Gore

N Engl J Med· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-1H/VISTA mediates immune evasion in acute myeloid leukemia.
Tae Kon Kim, Xue Han, Qianni Hu, Esten N Vandsemb, Carly M Fielder, Steven D Gore

J Clin Invest· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicenter phase Ib trial of the histone deacetylase inhibitor entinostat in combination with pembrolizumab in patients with myelodysplastic syndromes/neoplasms or acute myeloid leukemia refractory to hypomethylating agents.
Jan Philipp Bewersdorf, Rory M Shallis, Elad Sharon, Silvia Park, Rahul Ramaswamy, Steven D Gore

Ann Hematol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Berzosertib Plus Topotecan vs Topotecan Alone in Patients With Relapsed Small Cell Lung Cancer: A Randomized Clinical Trial.
Nobuyuki Takahashi, Zhonglin Hao, Liza C Villaruz, Jun Zhang, Jimmy Ruiz, Steven D Gore

JAMA Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Classification, risk stratification and response assessment in myelodysplastic syndromes/neoplasms (MDS): A state-of-the-art report on behalf of the International Consortium for MDS (icMDS).
Maximilian Stahl, Jan Philipp Bewersdorf, Zhuoer Xie, Matteo Giovanni Della Porta, Rami Komrokji, Steven D Gore

Blood Rev· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discordant pathologic diagnoses of myelodysplastic neoplasms and their implications for registries and therapies.
Edward J Gorak, Michael Otterstatter, Tareq Al Baghdadi, Nancy Gillis, James M Foran, Steven D Gore

Blood Adv· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Statin use, survival and incidence of thrombosis among older patients with polycythemia vera and essential thrombocythemia.
Nikolai A Podoltsev, Rong Wang, Rory M Shallis, Jessica M Stempel, Mengyang Di, Steven D Gore

Cancer Med· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current landscape of translational and clinical research in myelodysplastic syndromes/neoplasms (MDS): Proceedings from the 1 International Workshop on MDS (iwMDS) Of the International Consortium for MDS (icMDS).
Jan Philipp Bewersdorf, Zhuoer Xie, Rafael Bejar, Uma Borate, Jacqueline Boultwood, Steven D Gore

Blood Rev· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Equitable Access to Clinical Trials: How Do We Achieve It?
Ana Acuña-Villaorduña, Joaquina Celebre Baranda, Jessica Boehmer, Lola Fashoyin-Aje, Steven D Gore

Am Soc Clin Oncol Educ Book· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second malignancies among older patients with classical myeloproliferative neoplasms treated with hydroxyurea.
Rong Wang, Rory M Shallis, Jessica M Stempel, Scott F Huntington, Amer M Zeidan, Steven D Gore

Blood Adv· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expanding access to early phase trials: the CATCH-UP.2020 experience.
Joaquina C Baranda, Francisco J Diaz, Larry Rubinstein, Anthony F Shields, Farshid Dayyani, Steven D Gore

JNCI Cancer Spectr· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Agent Orange and dioxin-induced myeloid leukemia: a weaponized vehicle of leukemogenesis.
Rory M Shallis, Steven D Gore

Leuk Lymphoma· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of a robust and rapid liquid chromatography tandem mass spectrometric method for the quantitative analysis of navitoclax.
Susan C Scott, Nicole M Anders, Ping He, Avelina Hemingway, Steven D Gore

Biomed Chromatogr· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of a robust and rapid liquid chromatography tandem mass spectrometric method for the quantitative analysis of navitoclax.
Susan C Scott, Nicole M Anders, Ping He, Avelina Hemingway, Steven D Gore

Biomed Chromatogr· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis